Turner S D, Alexander D R
Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB2 4AT, UK.
Leukemia. 2005 Jul;19(7):1128-34. doi: 10.1038/sj.leu.2403797.
The nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) is generated as a t(2;5) chromosomal breakpoint product, typically in CD30(+) anaplastic large cell lymphomas. Activation of the NPM-ALK tyrosine kinase by NPM dimerisation causes autophosphorylation at multiple tyrosine residues and the consequent recruitment of a 'signalosome' that couples the fusion protein to pathways regulating mitogenesis and apoptosis. This review focuses on recent advances in our understanding of the transforming signals induced by this fusion protein in mouse models.
核磷蛋白-间变性淋巴瘤激酶(NPM-ALK)是作为t(2;5)染色体断点产物产生的,通常见于CD30(+)间变性大细胞淋巴瘤。NPM二聚化激活NPM-ALK酪氨酸激酶,导致多个酪氨酸残基发生自磷酸化,随后募集一个“信号体”,该信号体将融合蛋白与调节有丝分裂和细胞凋亡的信号通路相连接。本综述重点关注在小鼠模型中我们对这种融合蛋白诱导的转化信号的最新认识进展。